172 related articles for article (PubMed ID: 6149475)
41. Demonstration and characterization of immunoreactive methionine-enkephalin, leucine-enkephalin, methionine-enkephalin-Arg6-Gly7-Leu8 and methionine-enkephalin-Arg6-Phe7 in human phaeochromocytoma.
Yoshimasa T; Nakao K; Sakamoto M; Suda M; Morii N; Ikeda Y; Ishihara T; Manno M; Hamada S; Shimbo S
Acta Endocrinol (Copenh); 1984 Oct; 107(2):261-7. PubMed ID: 6495993
[TBL] [Abstract][Full Text] [Related]
42. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum.
Sirinathsinghji DJ; Nikolarakis KE; Reimer S; Herz A
Brain Res; 1990 Aug; 526(1):173-6. PubMed ID: 1981853
[TBL] [Abstract][Full Text] [Related]
43. Brain endo-oligopeptidase A, a putative enkephalin converting enzyme.
Camargo AC; Oliveira EB; Toffoletto O; Metters KM; Rossier J
J Neurochem; 1987 Apr; 48(4):1258-63. PubMed ID: 2880931
[TBL] [Abstract][Full Text] [Related]
44. [Met5]enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors.
Kanai M; Takahashi S; Kosaka K; Iwao K; Kobayashi H; Oka T
Eur J Pharmacol; 2002 Oct; 453(1):53-8. PubMed ID: 12393059
[TBL] [Abstract][Full Text] [Related]
45. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
Konkoy CS; Davis TP
J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
[TBL] [Abstract][Full Text] [Related]
46. Parallel distribution of methionine-enkephalin-Arg6-Gly7-Leu8 with methionine-enkephalin, leucine-enkephalin and methionine-enkephalin-Arg6-Phe7 in human and bovine brains.
Ikeda Y; Nakao K; Yoshimasa T; Sakamoto M; Suda M; Yanaihara N; Imura H
Life Sci; 1983; 33 Suppl 1():65-8. PubMed ID: 6664241
[TBL] [Abstract][Full Text] [Related]
47. Purification and characterization of a secreted arginine-specific dibasic cleaving enzyme from EL-4 cells.
Csuhai E; Safavi A; Hersh LB
Biochemistry; 1995 Sep; 34(38):12411-9. PubMed ID: 7547986
[TBL] [Abstract][Full Text] [Related]
48. Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations.
Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL
Regul Pept; 1991 Feb; 32(3):267-78. PubMed ID: 1678195
[TBL] [Abstract][Full Text] [Related]
49. Separate metabolic pathways for Leu-enkephalin and Met-enkephalin-Arg(6)-Phe(7) degradation by rat striatal synaptosomal membranes.
Benuck M; Berg MJ; Marks N
Neurochem Int; 1982; 4(5):389-96. PubMed ID: 20487892
[TBL] [Abstract][Full Text] [Related]
50. Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients.
Iadarola MJ; Ofri D; Kleinman JE
Life Sci; 1991; 48(20):1919-30. PubMed ID: 1708847
[TBL] [Abstract][Full Text] [Related]
51. A novel bovine spinal cord endoprotease with high specificity for dynorphin B.
Silberring J; Nyberg F
J Biol Chem; 1989 Jul; 264(19):11082-6. PubMed ID: 2567732
[TBL] [Abstract][Full Text] [Related]
52. Variations in opioid peptide levels during the estrous cycle in Sprague-Dawley rats.
Roman E; Ploj K; Gustafsson L; Meyerson BJ; Nylander I
Neuropeptides; 2006 Jun; 40(3):195-206. PubMed ID: 16540166
[TBL] [Abstract][Full Text] [Related]
53. Immunoreactive pro-enkephalin and prodynorphin products are differentially distributed within the nucleus of the solitary tract of the rat.
Lee HS; Basbaum AI
J Comp Neurol; 1984 Dec; 230(4):614-9. PubMed ID: 6151570
[TBL] [Abstract][Full Text] [Related]
54. Brain endopeptidase generates enkephalin from striatal precursors.
Knight M; Plotkin C; Tamminga CA
Peptides; 1982; 3(3):461-8. PubMed ID: 6750568
[TBL] [Abstract][Full Text] [Related]
55. Distribution of enkephalin-related peptides in rat brain: immunohistochemical studies using antisera to met-enkephalin and met-enkephalin Arg6Phe7.
Williams RG; Dockray GJ
Neuroscience; 1983 Jul; 9(3):563-86. PubMed ID: 6312371
[TBL] [Abstract][Full Text] [Related]
56. Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus.
Sandin J; Tan-No K; Kasakov L; Nylander I; Winter A; Silberring J; Terenius L
Peptides; 1997; 18(7):949-56. PubMed ID: 9357051
[TBL] [Abstract][Full Text] [Related]
57. Conversion of Met-enkephalin-Arg6-Phe7 by a purified brain carboxypeptidase (cathepsin A).
Marks N; Sachs L; Stern F
Peptides; 1981; 2(2):159-64. PubMed ID: 7291041
[TBL] [Abstract][Full Text] [Related]
58. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
Nylander I; Vlaskovska M; Terenius L
Psychopharmacology (Berl); 1995 Apr; 118(4):391-400. PubMed ID: 7568625
[TBL] [Abstract][Full Text] [Related]
59. Met-enkephalin binding to opiate receptors is not functionally coupled to biodegradation.
Nagy A; Gráf L; Lajtha A
Life Sci; 1983 Aug; 33(9):835-40. PubMed ID: 6310302
[TBL] [Abstract][Full Text] [Related]
60. Immunocytochemical evidence for the presence of Met-enkephalin and Leu-enkephalin in distinct neurons in the brain of the elasmobranch fish Scyliorhinus canicula.
Vallarino M; Bucharles C; Facchinetti F; Vaudry H
J Comp Neurol; 1994 Sep; 347(4):585-97. PubMed ID: 7814676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
